Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this podcast from the University of Wisconsin School of Medicine and Public Health, Marc Bellazzini, MD, discusses the presentation and management of acute coronary syndrome with Giorgio Gimelli, MD, FACC, associate professor of medicine in the Division of Cardiovascular Medicine at the University of Wisconsin School of Medicine and Public Health. To download the podcast, click here.
Related Articles
Patients continue to benefit from high-dose atorvastatin therapy for at least 5 years after acute coronary syndrome, according to a new study.
Study finds that black patients who visit the emergency department with ACS have more symptoms and higher symptom severity than white patients.
A recent study examines the comparative efficacy of prasugrel and clopidogrel in the treatment of patients who underwent percutaneous coronary intervention.
Patients who were treated for persistent depression after an acute coronary syndrome experienced improved outcomes during treatment, but worsened outcomes after treatment ended.
Latest Issues
$auto_registration$